MedOrion’s solution seamlessly combines behavioral science and AI to uncover members’ psychological motivations, achieving a notable 5% increase in CAHPS GNC and a 26% reduction in complaint rates
LOUISVILLE, Ky., Nov. 14, 2024 /PRNewswire/ — MedOrion, a leading healthcare software company, announces today the release of a new CAHPS solution, expanding its proven behavioral science platform to the member satisfaction domain.
Its innovative Electronic Behavioral Record (EBR) engine has already transformed quality outcomes for leading health plans in the pharmacy and HEDIS spaces. With its new CAHPS solution, MedOrion continues to empower health plans to drive results across multiple-star rating measures, providing a holistic and cost-effective platform.
To celebrate the launch, MedOrion is hosting a free webinar, “Unlocking New CAHPS Insights: Fireside Chat with Industry Experts,” on December 4th, 2024, at 11:00 AM EST.
Attendees will gain actionable strategies from a panel of distinguished experts, including David Reid, Senior Director of Medicare Member Experience at Florida Blue; Misty Roberts, VP of Quality & Performance Outcomes at CareSource; and Dr. David B. Nash, Professor of Health Policy at Jefferson College of Population Health. Register here to secure your spot.
CAHPS scores pose a unique challenge for health plans, as they rely on unpredictable member sampling through surveys. MedOrion’s solution leverages its proprietary, scalable, behavioral science engine (EBR) to identify members at risk of low satisfaction scores and to effectively engage and persuade ALL OF THEM to take actions that increase their likelihood of becoming satisfied members.
This unique approach facilitates meaningful interactions even with challenging populations, such as those with Social Risk Factors (SRFs), helping health plans proactively improve the member experience while advancing health equity.
About MedOrion
MedOrion develops a healthcare SaaS solution that helps organizations improve clinical quality and financial outcomes by continually uncovering and addressing members’ psychological barriers to action and automatically persuading them to adhere to medical guidelines.
With over 4 million members managed, MedOrion has consistently delivered impressive results for industry leaders, translating behavioral insights into substantial gains in health outcomes.
Photo – https://healthtechnologynet.com/wp-content/uploads/2024/11/Medorion_Webinar_Invite.jpg
SOURCE MedOrion
CTC PD-L1 assay enables longitudinal monitoring of PD-L1 status in lung cancer patients and may…
RESULTS FROM WORK TO DEVELOP A PARSORTIX-BASED Her2 assay KIT SHOWCASED AT INTERNATIONAL LIQUID BIOPSY…
Learn How at an Exclusive Webinar on Nov. 20th Hosted by Medical Economics and Specialdocs …
A Transformative Virtual Event Celebrates Unity, Hope, and Global Peace, Featuring Renowned Guests and Visionary…
Launched non-medical sales in Ohio with initial sales accounting for 38% of total state level…
Vancouver, British Columbia--(Newsfile Corp. - November 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB:…